Diagnos Inc.
DGNOF
$0.20
$0.00-1.90%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 48.70K | 56.40K | 62.00K | 74.80K | 93.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 48.70K | 56.40K | 62.00K | 74.80K | 93.20K |
| Cost of Revenue | 1.07M | 985.80K | 942.00K | 750.70K | 728.50K |
| Gross Profit | -1.02M | -929.40K | -880.00K | -675.90K | -635.40K |
| SG&A Expenses | 2.14M | 2.22M | 2.18M | 2.06M | 1.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.21M | 3.21M | 3.12M | 2.81M | 2.42M |
| Operating Income | -3.16M | -3.15M | -3.06M | -2.74M | -2.33M |
| Income Before Tax | -3.37M | -3.40M | -3.35M | -3.07M | -2.74M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.37 | -3.40 | -3.35 | -3.07 | -2.74 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.37M | -3.40M | -3.35M | -3.07M | -2.74M |
| EBIT | -3.16M | -3.15M | -3.06M | -2.74M | -2.33M |
| EBITDA | -3.10M | -3.08M | -2.99M | -2.66M | -2.25M |
| EPS Basic | -0.03 | -0.03 | -0.04 | -0.03 | -0.03 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.03 | -0.03 | -0.04 | -0.03 | -0.03 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 420.50M | 396.83M | 376.92M | 353.04M | 329.01M |
| Average Diluted Shares Outstanding | 420.50M | 396.83M | 376.92M | 353.04M | 329.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |